Rajeev A. Modi - 15 May 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: Executive Vice President U.S. Pet Health and Global Digital Transformation
Issuer ticker: ELAN
Reported as of: 15 May 2026
Net transaction value: +$99,939
SEC form: 4
Accepted by SEC: 19 May 2026, 16:39:20 UTC
Prior SEC filing: 05 May 2026
Next SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi

Key filing fact

Rajeev A. Modi filed Form 4 for Elanco Animal Health Inc (ELAN) on 19 May 2026.

Key facts

This page summarizes Rajeev A. Modi's Form 4 filing for Elanco Animal Health Inc (ELAN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 May 2026, 16:39.

Change

Previous filing in this sequence was filed on 05 May 2026.
Current net transaction value: +$99,939.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916473 Primary reporting owner

Modi Rajeev A.

Relationship: Executive Vice President U.S. Pet Health and Global Digital Transformation
Address: C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi
Signature date: 19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Purchase

Transaction value: $99,939
Shares: +4,911
Change %: +3.2%
Price: $20.35
Shares after: 160,812
Date: 15 May 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares: +74
Change %: +0.8%
Price: $19.86^*
Shares after: 9,340
Date: 15 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 74
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

Footnote F2

Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

SEC remarks

Executive Vice President U.S. Pet Health and Global Digital Transformation